Axis-Shield PLC - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Axis-Shield PLC Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Axis-Shield PLC(AXIS-SHIELD). The Group's principal activity is developing and manufacturing of vitro diagnostic products for use in the laboratory. It is organised in three divisions: Direct Distribution sells both in-house products and third party products. Point-of-Care comprises all activities associated with tests performed at the point of consultation with healthcare professionals. Laboratory concentrates on in vitro diagnostics tests for use in the clinical laboratory. Key clinical areas are cardiovascular disease, cerebrovascular disease and dementia, rheumatoid arthritis, alcohol-related disease, diabetes, infectious diseases and vitamin B12 deficiency. The Group operates in the United Kingdom and the Nordic Region. On 01-Jan-2008, the Group acquired the Point-of-Care business and inventories, and certain other assets of Nycomed Pharma AG.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report